دورية أكاديمية
Vamorolone: First Approval
| العنوان: | Vamorolone: First Approval |
|---|---|
| المؤلفون: | Susan Keam |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Medicine, vamorolone, First Approval, Adis Drug Review, Adis Insight Report, dissociative corticosteroid, Duchenne Muscular Dystrophy |
| الوصف: | Declarations Funding The preparation of this review was not supported by any external funding. Authorship and Conflict of interest During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the authors on the basis of scientific completeness and accuracy. Susan J. Keam is a contracted employee of Adis International Ltd/Springer Nature, and declares no relevant conflicts of interest. All authors contributed to this article and are responsible for its content. Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability Not applicable. Additional information about this Adis Drug Review can be found here . Abstract Vamorolone (AGAMREE®) is an oral, selective, dissociative corticosteroid developed by ReveraGen BioPharma and Santhera Pharmaceuticals for the treatment of patients with muscular dystrophy. Vamorolone was approved in October 2023 for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older in the USA and received a positive opinion in the EU in October 2023 for the treatment of DMD in patients 4 years of age and older. This article summarizes the milestones in the development of vamorolone leading to this first approval for DMD. © Springer Nature Switzerland AG 2023 |
| نوع الوثيقة: | text |
| اللغة: | unknown |
| العلاقة: | https://figshare.com/articles/online_resource/Vamorolone_First_Approval/24654435Test |
| DOI: | 10.6084/m9.figshare.24654435.v1 |
| الإتاحة: | https://doi.org/10.6084/m9.figshare.24654435.v1Test https://figshare.com/articles/online_resource/Vamorolone_First_Approval/24654435Test |
| حقوق: | CC BY-NC 4.0 |
| رقم الانضمام: | edsbas.B11F715E |
| قاعدة البيانات: | BASE |
| DOI: | 10.6084/m9.figshare.24654435.v1 |
|---|